Gadian, Aicel .

HRN: 26-63-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2025
CEFUROXIME 1.5GM (VIAL)
01/30/2025
01/30/2025
IV
1.5 G
Loading Dose
Bartholin Gland Abscess
Waiting Final Action 
01/30/2025
CEFUROXIME 500MG (TAB)
01/30/2025
02/06/2025
ORAL
500 Mg
BID
Bartholin Gland Abscess
Waiting Final Action 
01/30/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/30/2025
02/06/2025
IV
600 Mg
Every 8 Hours
Bartholin Gland Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: